Leukemia TOP TEN

The top ten charts the articles that have been downloaded most often, in HTML format, from the Leukemia website in recent weeks. The chart does not rank the quality, scientific significance or citation impact of the content. However, it may bring articles to your attention that you might not have otherwise noticed. We hope you enjoy them.

October 2009

1. MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM

   A A Rambal, Z L G Panaguiton, L Kramer, S Grant and H Harada

   doi:10.1038/leu.2009.80

   Abstract | Full Text | PDF | Supplementary information

2. Stem-cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards!

   M Mohty

   doi:10.1038/leu.2009.109

   Abstract | Full Text | PDF

3. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

   A Palumbo, O Sezer, R Kyle, J S Miguel, R Z Orlowski, P Moreau, R Niesvizky, G Morgan, R Comenzo, P Sonneveld, S Kumar, R Hajek, S Giralt, S Bringhen, K C Anderson, P G Richardson, M Cavo, F Davies, J Bladé, H Einsele, M A Dimopoulos, A Spencer, A Dispenzieri, T Reiman, K Shimizu, J H Lee, M Attal, M Boccadoro, M Mateos, W Chen, H Ludwig, D Joshua, J Chim, V Hungria, I Turesson, B G M Durie and S Lonial

   doi:10.1038/leu.2009.122

   Abstract | Full Text | PDF

4. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

   M Dimopoulos, E Terpos, R L Comenzo, P Tosi, M Beksac, O Sezer, D Siegel, H Lokhorst, S Kumar, S V Rajkumar, R Niesvizky, L A Moulopoulos and B G M Durie

   doi:10.1038/leu.2009.89

   Abstract | Full Text | PDF

5. Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

   F J Giles, M O'Dwyer and R Swords

   doi:10.1038/leu.2009.111

   Abstract | Full Text | PDF

6. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review FREE

   R Fonseca, P L Bergsagel, J Drach, J Shaughnessy, N Gutierrez, K Stewart, G Morgan, B Van Ness, M Chesi, S Minvielle, A Neri, B Barlogie, W M Kuehl, P Liebisch, F Davies, S Chen-Kiang, B G M Durie, R Carrasco, Orhan Sezer, Tony Reiman, Linda Pilarski and H Avet-Loiseau

   doi:10.1038/leu.2009.174

   Abstract | Full Text | PDF

7. Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues

   J M Goldman, A R Green, T Holyoake, C Jamieson, R Mesa, T Mughal, F Pellicano, D Perrotti, R Skoda and A M Vannucchi

   doi:10.1038/leu.2009.142

   Abstract | Full Text | PDF

8. Vorinostat interferes with Wnt and NF-B pathways in the M-07e cell line

   S Galimberti, M Canestraro, R Maffei, R Marasca, F Guerrini, S Piaggi, E Ciabatti and M Petrini

   doi:10.1038/leu.2009.119

   Abstract | Full Text | PDF

9. Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism

   P Gelebart, Z Zak, M Anand, J Dien-Bard, H M Amin and R Lai

   doi:10.1038/leu.2009.100

   Abstract | Full Text | PDF | Supplementary information

10. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms

    A Tefferi and J W Vardiman

    doi:10.1038/sj.leu.2404955

    Abstract | Full Text | PDF

Main navigation

NPG resources

• British Journal of Cancer
• Bone Marrow Transplantation
• Nature Reviews Cancer
• Nature Clinical Practice Oncology
• Nature Medicine